Successful treatment of iron overload with phlebotomies in two siblings with congenital dyserythropoietic anemia--type II (CDA-II).

Successful treatment of iron overload by phlebotomies has been reported in two splenectomized siblings with congenital dyserythropoietic anemia--type II (CDA-II). In both patients 400 ml of blood were withdrawn every month. During three years 12 200 ml of blood were removed. The serum ferritin levels decreased from 1450,4 microg/L and 1131,7 microg/L to 447 microg/L and 457 microg/l, respectively. The transferrin saturation dropped from 0,99 at the start of the therapy to 0,64 and 0,86, respectively. The values of Hb, Hct, erythrocyte counts and MCV did not change as well as did not change reticulocyte counts, reticulocyte index, and RDW. Both patients tolerated repeated phlebotomies well. The decrease of bilirubin and normal values of haptoglobin might be the concequence of diminished destruction of erythrocytes and their precursors. Our observation confirms that phlebotomies can be used with success in CDA patients with mild anemia as treatment modality of iron overload.

[1]  W. Wood,et al.  Advances in the understanding of the congenital dyserythropoietic anaemias , 2005, British journal of haematology.

[2]  H. Heimpel,et al.  Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. , 2003, Blood.

[3]  T. Roskams,et al.  NONIATROGENIC HAEMOCHROMATOSIS IN CONGENITAL DYSERYTHROPOIETIC ANAEMIA TYPE II IS NOT RELATED TO C282Y AND H63D MUTATIONS IN THE HFE GENE : REPORT ON TWO BROTHERS , 2002, Acta clinica Belgica.

[4]  R. Fischer,et al.  Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry , 1999, American journal of hematology.

[5]  P. Nielsen,et al.  Successful treatment of iron overload by phlebotomies in a patient with severe congenital dyserythropoietic anemia type II. , 1997, Blood.

[6]  S. Wickramasinghe.  Response of CDA type I to alpha‐interferon , 1997, European journal of haematology.

[7]  C. McLaren,et al.  Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. , 1994, The New England journal of medicine.

[8]  S. Lewis,et al.  Hereditary Erythroblastic Multinuclearity Associated with a Positive Acidified‐Serum Test: a Type of Congenital Dyserythropoietic Anaemia , 1969, British journal of haematology.

[9]  L. Chrobák,et al.  Excess of Pappenheimer bodies (siderocytes) in two splenectomized siblings with congenital dyserythropoietic anemia--type II (CDA-II) and iron overload. , 2004, Acta medica.

[10]  L. Chrobák,et al.  Congenital dyserytropoietic anaemia, type II (HEMPAS) in three siblings. , 1980, Folia haematologica.